Calistoga Pharmaceuticals Inc is categorized under Testing Services in Seattle, WA and active since 2006.
Calistoga Pharmaceuticals Inc was established in 2006, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Testing Services business, which does work in the B2B market, and is classified as a Testing Services, under code number 611710 by the NAICS.
If you are seeking more information, feel free to contact Carol G Gallagher at the company’s single location by writing to 199 East Blaine St, Seattle, Washington WA 98102 or by phoning (206) 728-4700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Calistoga Pharmaceuticals Inc |
| Contact Person: | Carol G Gallagher |
| Address: | 199 East Blaine St, Seattle, Washington 98102 |
| Phone Number: | (206) 728-4700 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Testing Services |
| SIC Code: | 8748 |
| NAICS Code: | 611710 |
| Share This Business: |
Calistoga Pharmaceuticals Inc was started in 2006 to provide professional Testing Services under the SIC code 8748 and NAICS code 611710. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Carol G Gallagher for inquiries that concern Calistoga Pharmaceuticals Inc by calling the company number (206) 728-4700, as your correspondence is most welcome. Additionally, the physical location of the single location of Calistoga Pharmaceuticals Inc can be found at the coordinates 47.634698,-122.32608 as well as the street address 199 East Blaine St in Seattle, Washington 98102.
For its online presence, you may visit Calistoga Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.